Home > Healthcare > Healthcare IT > Payer/Provider Solutions > Digital Diabetes Management Market

Digital Diabetes Management Market Trends

Report ID: GMI4903
Published Date: Jun 2023
Report Format: PDF

Download Free Sample

Digital Diabetes Management Market Trends

The advent of big data analytics and AI in diabetes devices will create ample opportunities for the market. AI technology has gained immense traction in insulin monitoring, insulin injection guidance, diabetes prediction, and exercise guidance in diabetes management. Moreover, a remarkable growth in AI technology is helping healthcare providers get access to large data sets of diabetes patients. This high availability of information is helping patients get customized treatment for enhanced clinical outcomes thus, stimulating industry revenue streams.

Authors: Mariam Faizullabhoy , Pratiksha Kamthe

Frequently Asked Questions (FAQ) :

In 2022, the digital diabetes management industry was valued at USD 18.9 billion and will grow at 20% CAGR from 2023 to 2032, attributed to the growing prevalence of diabetes globally.

The market share from the services segment will grow at more than 18.5% CAGR from 2023 to 2032, owing to rapid advancements in diabetes management software and apps.

North America digital diabetes management market size reached over USD 6 billion in 2022, attributed to the favorable government initiatives for diabetes treatment.

Major digital diabetes management industry players include Abbott Laboratories, F.Hoffmann-La Roche Ltd, Senseonics, Tandem Diabetes Care, Inc, Medtronic Plc, Dexcom, Inc, and Insulet Corporation, among others.